CAROL ALEXANDER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner CHICAGO, IL NPI 1689609554
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner IL Gilead Sciences, Inc. All categories
General Payments — all program years on this page
$2,062.30
- Category: General Payments
- Program years: PY2021–2024
- Record count: 21
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $818.90 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $818.90 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $235.49 | 2 |
| Amgen Inc. | $215.59 | 2 |
| Phathom Pharmaceuticals, Inc. | $92.53 | 1 |
| Novo Nordisk AS | $92.46 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $91.57 | 1 |
| Lilly USA, LLC | $91.26 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100277680 | Novo Nordisk Inc | $92.46 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115415694 | Amgen Inc. | $124.55 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115415705 | Amgen Inc. | $91.04 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133652284 | Gilead Sciences, Inc. | $112.61 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133652286 | Gilead Sciences, Inc. | $122.88 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135577518 | Lilly USA, LLC | $91.26 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151144154 | Phathom Pharmaceuticals, Inc. | $92.53 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153520656 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $91.57 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.